Cytek Biosciences, Inc.
Cytek Biosciences, Inc.（CTKB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ctkb · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$5.50
Consensus
$5.13
+27.0% upside
Low
$4.75
Median: $5.125 · Last Close: $4.04
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.13
27.0% upside
High Target
$5.5
36.1%
Low Target
$4.75
17.6%
Current Price
$4.04
as of today
Based on analyst price targets, the CTKB stock price prediction for the next 12 months ranges from $4.75 to $5.5. The consensus CTKB price forecast of $5.13 implies 27.0% upside from the current price of $4.04.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.18 | ↑ 3.47% |
1-day model range: $4.15–$4.21. Peak: $4.21 (+3.47%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -31.1% |
| 2028 | $2 | -42.9% |
| 2029 | $2 | -48.2% |
| 2030 | $2 | -50.9% |
| 2031 | — | -52.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CTKB · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-05-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-05-28 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-05-12 | Goldman Sachs | Maintains | Sell→Sell |
| 2025-03-19 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-03-04 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-08-13 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cytek Biosciences, Inc. (CTKB) stock. Of the recent 30 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover CTKB.
分析师推荐趋势
CTKB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$197M
↓ 11.7% YoY
Revenue Next Year
$209M
↑ 6.2% YoY
EPS This Year
$-0.13
EPS Next Year
$-0.35
↑ 173.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CTKB EPS of $-0.13 for the current fiscal year, based on estimates from 2 analysts. The CTKB revenue forecast is $197M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CTKB 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CTKB 的共识目标价为 $5.13（+27.0% 上行空间），分析师共识为 Buy。
CTKB 的短期预测（明日）为 $4.18（+3.47%）。 CTKB 对 2027 年的股价预测均值为 $3。 CTKB 对 2030 年的预测区间为 $2–$2。
Cytek Biosciences, Inc. 在 NASDAQ 上市，代码 CTKB。CTKB 在 2027 年的整体展望偏积极，在覆盖分析师中约 60% 对应 Buy 共识。
常见问题
CTKB 预测 · 8 个问题根据 5 位华尔街分析师，CTKB 的 12 个月平均目标价为 $5.13，最高 $5.50、最低 $4.75。若有图表，中位目标价可在上方查看。相对当前价 $4.04，隐含约 +27.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.